FDA Inspection
Stacy R. Smith, M.D.Stacy R. Smith, M.D. – FDA Inspection, Jul 26, 2017
Record Details
This FDA Inspection record concerns Stacy R. Smith, M.D., with an inspection on July 26, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 1cfb1def-d41d-4a62-a4a3-c439d616d325
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1019478
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Stacy R. Smith, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 7, 2019 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Stacy R. Smith, M.D.
- FDA Inspection 1110323 - 2019-10-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.